Low-Dose Quetiapine for Sleep, PRN Anxiety, and Agitation

Why Quetiapine Should Be Avoided for These Indications

• The American Academy of Sleep Medicine guidelines explicitly state that atypical antipsychotics like quetiapine are only suitable for patients with comorbid conditions who may benefit from the primary action of these drugs, not for primary insomnia 3
• Quetiapine has no established role for PRN use in anxiety or agitation 3

Evidence-Based Alternatives

For Insomnia

• The American Academy of Sleep Medicine recommends Cognitive Behavioral Therapy for Insomnia (CBT-I) as the most effective and recommended treatment for chronic insomnia 1, 2, 3
• FDA-approved hypnotics, such as benzodiazepine receptor agonists (zolpidem, eszopiclone, zaleplon, or temazepam) and ramelteon, should be used at the lowest effective dose for the shortest duration possible, with regular reassessment 1, 2, 3, 6

For Anxiety

• The American Academy of Child and Adolescent Psychiatry recommends SSRIs or SNRIs as the evidence-based pharmacological treatments for anxiety disorders 7
• Benzodiazepines may be used short-term for acute anxiety but carry risks of tolerance, dependence, and cognitive impairment 4, 5

For Agitation

• The American Family Physician recommends buspirone (5-20 mg TID) for mild-moderate agitation, but requires 2-4 weeks to become effective 4, 5, 8
• Mood-stabilizing agents, such as trazodone (25-400 mg/day) and divalproex sodium (125 mg BID), are preferred over antipsychotics for agitation in specific contexts like dementia 4, 5

Critical Clinical Pitfalls

• Quetiapine should not be used PRN due to lack of evidence for this indication and increased unpredictable adverse effects 3
• Antihistamines (diphenhydramine) and herbal supplements (valerian, melatonin) are not recommended for chronic insomnia due to lack of efficacy and safety data 1, 2, 3, 6